Key result
Single-lead ECG and PPG devices improve early home detection and management of AF.
Why the study?
Diagnosing and monitoring AF is challenging due to its intermittent and asymptomatic nature, but is crucial for effective treatment and prevention of serious complications.
Wearable devices using single-lead ECG and PPG technologies provide accessible and convenient options for early home detection of atrial fibrillation.
INTRODUCTION: Atrial fibrillation (AF) is the most common cardiac arrhythmia, whose incidence and prevalence have increased over the last 20 years and will continue to increase over the next 30 years. It is characterized by irregular atrial activation, leading to complications as stroke and heart failure. Due to its intermittent and asymptomatic nature, diagnosing and monitoring AF is challenging but crucial for effective treatment and prevention of serious complications. AREAS COVERED: This study reviews noninvasive medical devices available for home detection of AF by analyzing cardiac activity through ECG or photoplethysmography (PPG). The review covers the technologies underlying single-lead ECG acquisition and PPG sensors, and describes how these are used, also in combination, in home-use medical devices (including smartwatches and wristbands). EXPERT OPINION: Single-lead ECG and PPG technologies in consumer electronics have revolutionized AF detection, making it more accessible and convenient for patients. Despite some limitations in signal quality and diagnostic scope, these devices offer significant benefits for early AF detection and management. The use of wearable devices, including smartwatches and wristbands, for heart activity monitoring represents a promising advancement in patient-lead healthcare, potentially leading to better outcomes through timely medical intervention and improved patient engagement in managing their condition.
No takes yet. Share an insight, caveat, or question.
Ricci et al. (2025) conducted a review in Atrial fibrillation. Noninvasive medical devices (single-lead ECG and PPG) was evaluated. Noninvasive medical devices using single-lead ECG and PPG technologies offer significant benefits for early home detection and management of atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: